---
title: "EXEL.US (EXEL.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/EXEL.US/news.md"
symbol: "EXEL.US"
name: "EXEL.US"
parent: "https://longbridge.com/en/quote/EXEL.US.md"
datetime: "2026-05-20T18:26:40.207Z"
locales:
  - [en](https://longbridge.com/en/quote/EXEL.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/EXEL.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/EXEL.US/news.md)
---

# EXEL.US (EXEL.US) — Related News

### [Thrivent Financial for Lutherans Increases Holdings in Exelixis, Inc. $EXEL](https://longbridge.com/en/news/286667815.md)
*2026-05-17T09:23:59.000Z*
> Thrivent Financial for Lutherans significantly increased its stake in Exelixis, Inc. by 1,821.0% during Q4, owning 1,188

### [Ameritas Advisory Services LLC Purchases Shares of 34,270 Exelixis, Inc. $EXEL](https://longbridge.com/en/news/286523415.md)
*2026-05-15T07:17:21.000Z*
> Ameritas Advisory Services LLC acquired 34,270 shares of Exelixis, Inc. (NASDAQ:EXEL) valued at approximately $1.5 milli

### [Exelixis, Inc. $EXEL Position Trimmed by Danske Bank A S](https://longbridge.com/en/news/285685360.md)
*2026-05-08T08:00:06.000Z*
> Danske Bank A S has significantly reduced its stake in Exelixis, Inc. by 99.4%, now holding only 1,500 shares after sell

### [Guggenheim Remains a Hold on Exelixis (EXEL)](https://longbridge.com/en/news/285502987.md)
*2026-05-07T07:25:43.000Z*
> Guggenheim has maintained a Hold rating on Exelixis (EXEL), with shares closing at $48.70. The analyst consensus suggest

### [Exelixis (NASDAQ:EXEL) Price Target Raised to $47.00](https://longbridge.com/en/news/285418662.md)
*2026-05-06T17:57:28.000Z*
> Stifel Nicolaus raised Exelixis' price target from $44.00 to $47.00, maintaining a "hold" rating. The new target suggest

### [](https://longbridge.com/en/news/285414305.md)
*2026-05-06T16:57:01.000Z*
> Exelixis shares are trading higher after Wells Fargo raised its price target on the stock from $35 to $40.

### [Exelixis | 10-Q: FY2026 Q1 Revenue Beats Estimate at USD 610.81 M](https://longbridge.com/en/news/285302549.md)
*2026-05-06T03:11:57.000Z*
### [Analyst Reiterates Buy on Exelixis, Citing STELLAR-304 Momentum, Cabometyx Durability, and Share Repurchases](https://longbridge.com/en/news/285286415.md)
*2026-05-06T00:25:19.000Z*
> William Blair analyst Andy Hsieh has reiterated a Buy rating on Exelixis (EXEL) due to strong commercial performance and